Sight Sciences
SGHT | NASDAQ
$10.59
-$0.24 (-2.22%)
At close: Nov 16, 2026, 4:00 PM ET
$10.59
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.22%
(1D)No price chart data available for 1D timeframe.
Rating
49
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #307/1021 (Top 30%)
Key Statistics
Market Data
Market Cap $588.58M
1D Range
10.51 10.95
52W Range
3.45 11.01
Valuation (TTM)
PE -20.37
PB 11.98
EV/EBITDA -22.68
Valuation (NTM)
Forward PE N/A
Forward PEG 0.86
Price Target $10.50
Cash Flow
FCF Yield -2.9%
SBC Adj. FCF Yield -4.8%
SBC Impact -66.8%
Margins
Gross Margin 87.7%
Operating Margin -29.5%
FCF Margin -19.1%
Growth (CAGR)
Revenue 3Y | 5Y 2.2% |
15.4%
Dil EPS 3Y | 5Y 30.7% |
26.4%
FCF 3Y | 5Y 17.6% |
33.3%
Returns
ROA -27.1%
ROE -51.7%
ROIC -28.6%
Financial Health
Net Cash
$36.37M
Current Ratio 5.04
Interest Coverage -9.95
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its p...
Sector Healthcare
Industry Medical - Devices
Employees 186
IPO Date Jul 15, 2021
Website www.sightsciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.12
Beat +2.64%
YoY:
+25.00% REV
$24.92M
Beat +5.83%
YoY:
+25.20%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
6
Consensus
Buy
Price Target
$10.50
Downside
-0.85%
Buy (4)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SGHT